‹ All Posts
CA Omkar Bhutada - SEBI Reg IA

15th May · SEBI-Registered Analyst

GLAND Pharma monthly chart is interesting — this is stronger than a simple breakout.

GLAND
What stands out From 2021 highs (~₹4,000+) the stock went through a massive corrective phase. After bottoming around ₹1,000–1,200, price spent a long time building a broad accumulation structure. I can see a contracting triangle/wedge formation with: Rising support trendline Falling resistance trendline Current price around ₹1,910 is pressing against the upper boundary. The latest candle is a strong bullish expansion candle (+9%), suggesting momentum is returning. This kind of structure often produces powerful moves when multi-year bases resolve upward. Trade levels Aggressive entry: ₹1,900–1,930 Safer entry: Monthly close above ₹2,000–2,050 Stop loss: ₹1,700–1,740 (Below recent swing and trendline support) Potential targets Measured move from the pattern roughly suggests: Target 1: ₹2,200–2,250 Target 2: ₹2,700–2,800 Stretch target: ₹3,000+ The chart itself projects a move around 60%+, which aligns with the size of the compression. Structure quality score: 9.1/10 Why high: ✅ Multi-year base ✅ Compression before expansion ✅ Higher lows ✅ Breakout attempt after long correction ✅ Huge upside if structure resolves Why not perfect: ❌ Monthly breakout is not fully confirmed yet ❌ Needs sustained close above trendline with participation

#WatchOutFor#Today’sTradingSetup#StockInNews#TechnicalViews#FundamentalViews
GLAND_2026-05-15_09-11-23.png
734 likes·55 comments